Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Chevron Corp (CVX) vs Cassava Sciences Inc (FLNA) Price & Performance

Chevron CorpTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Chevron Corp vs Cassava Sciences Inc — how do they compare? Chevron Corp trades at $196 (market cap $385.77B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Chevron Corp is far larger — about 8079× Cassava Sciences Inc's market cap, and Chevron Corp pays a 3.62% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

CVXFLNA
Market Cap
$385.77B$47.75M
Volume
9,807,834
Sector
EnergyHealth
52-Week High
$211.14$4.64
52-Week Low
$146.72$0.87
Enterprise Value
$414.31B-$34.93M
Dividend Yield
3.62%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Chevron Corp

CVX trades at $194.9, up 4.47% today, with a bullish technical signal and strong analyst support. Recent earnings consistently beat expectations, with Q2 2026 EPS of $6.06 exceeding the $5.55 forecast. The company maintains solid profitability with a 9.87% net margin and 12.25% ROE, supported by a $13.8 billion investment in Argentina's Vaca Muerta shale project announced on June 2, 2026 (Reuters).

Outlook remains positive with a consensus price target of $214.25, implying 10% upside. Risks include declining revenue from $184.43B in 2025 and exposure to volatile oil prices, but high oil prices and strategic expansions provide growth catalysts. The stock offers a steady dividend of $1.78 per half-year.

Cassava Sciences Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Chevron Corp

Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.

Read more on CVX

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA